Integral Health Asset Management »

Beigene shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Beigene (BGNE) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Beigene

Tip: Access up to 7 years of quarterly data

All positions including Beigene held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beigene by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.3M 40k 156.39
2020-09-30 $4.2M 15k 286.41
2020-06-30 $1.9M 10k 188.40

More positions owned by Integral Health Asset Management

Viking Therapeutics Put Option (VKTX)
Insmed Com Par $.01 (INSM)
Tenet Healthcare Corp Com New (THC)
Boston Scientific Corporation (BSX)
Cytokinetics Com New (CYTK)
Merck & Co (MRK)
Encompass Health Corp (EHC)
Walgreen Boots Alliance (WBA)
Anthem (ELV)
Abbvie (ABBV)
Universal Hlth Svcs CL B (UHS)
Novartis Sponsored Adr (NVS)
Tarsus Pharmaceuticals (TARS)
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX)
Longboard Pharmaceuticals In (LBPH)

View all positions for Integral Health Asset Management

Top funds holding Beigene

Baker Bros. Advisors
Hillhouse Capital Advisors
PRIMECAP Management Company
Baillie Gifford & Co
T. Rowe Price Associates
FMR
BlackRock
Boxer Capital
Artal Group
Public Investment Fund
Bank of America Corporation
First Trust Advisors
M&G
M&g Investment Management
Baird Financial

View all funds holding Beigene